Skip to menu Skip to content Skip to footer
The University of Queensland
  • Study
  • Research
  • Partners and community
  • About
Institute for Molecular Bioscience
  • Home
  • About
    • About
    • Board
    • Annual reports
    • UN Sustainable Development Goals
    • Diversity and inclusion
    • Art and Science at IMB
    • History
  • People
    • People
    • Executive Director
    • Senior Leadership Team
    • Research leaders
    • Women in science
    • Ambassadors
    • Early-Mid Career Researchers (EMCRs)
  • Research
    • Research
    • > Research Groups
    • > Research Centres
    • > Research Facilities
    • > Partner with us
    • Cardiovascular disease
    • Antimicrobial resistance
    • Venom
    • Endometriosis
    • COVID-19
  • Study
    • Study
    • PhD
    • Masters
    • Honours
    • Undergraduate
    • Scholarships
    • Students of IMB Association (SIMBA)
  • Get Involved
    • Get Involved
    • Events
    • Become a Corporate Partner
    • Join the Director's Circle
    • Join our Alumni
    • Soils for Science
    • Become an IMB Champion
    • The Edge Magazine
    • Science Journalist-in-Residence
  • News
  • Donate
  • Contact us
  • Study
  • Research
  • Partners and community
  • About
  • UQ home
  • News
  • Events
  • Give
  • Contact
  • UQ home
  • News
  • Events
  • Give
  • Contact
Institute for Molecular Bioscience
  • Home
  • About
    • Board
    • Annual reports
    • UN Sustainable Development Goals
    • Diversity and inclusion
    • Art and Science at IMB
    • History
  • People
    • Executive Director
    • Senior Leadership Team
    • Research leaders
    • Women in science
    • Ambassadors
    • Early-Mid Career Researchers (EMCRs)
  • Research
    • > Research Groups
    • > Research Centres
    • > Research Facilities
    • > Partner with us
    • Cardiovascular disease
    • Antimicrobial resistance
    • Venom
    • Endometriosis
    • COVID-19
  • Study
    • PhD
    • Masters
    • Honours
    • Undergraduate
    • Scholarships
    • Students of IMB Association (SIMBA)
  • Get Involved
    • Events
    • Become a Corporate Partner
    • Join the Director's Circle
    • Join our Alumni
    • Soils for Science
    • Become an IMB Champion
    • The Edge Magazine
    • Science Journalist-in-Residence
  • News
  • Donate
  • Contact us

Ms Kai-Chen Wu

Principal Research Technician/Scientist/Engineer
Institute for Molecular Bioscience
+61 7 334 62386
k.wu2@uq.edu.au
Ms Kai-Chen Wu

Publications

Journal Articles (16)
Conference Papers (2)

Journal Articles

Poon, Eunice K., Liu, Ligong, Wu, Kai‐Chen, Lim, Junxian, Sweet, Matthew J., Lohman, Rink‐Jan, Iyer, Abishek and Fairlie, David P. (2024). A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis. British Journal of Pharmacology, 181 (23), 4804-4821. doi: 10.1111/bph.17306
Gerokonstantis, Dimitrios Triantafyllos, Mantzourani, Christiana, Gkikas, Dimitrios, Wu, Kai-Chen, Hoang, Huy N., Triandafillidi, Ierasia, Barbayianni, Ilianna, Kanellopoulou, Paraskevi, Kokotos, Alexandros C., Moutevelis-Minakakis, Panagiota, Aidinis, Vassilis, Politis, Panagiotis K., Fairlie, David P. and Kokotos, George (2023). N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity. Journal of Medicinal Chemistry, 66 (20), 1-20. doi: 10.1021/acs.jmedchem.3c01422
Wu, Kai-Chen, Condon, Nicholas D., Hill, Timothy A., Reid, Robert C., Fairlie, David and Lim, Junxian (2023). Ras related protein Rab5a regulates complement C5a receptor trafficking, chemotaxis and chemokine secretion in human macrophages. Journal of Innate Immunity, 15 (1), 468-484. doi: 10.1159/000530012
de Araujo, Aline D., Lim, Junxian, Wu, Kai-Chen, Hoang, Huy N., Nguyen, Huy T. and Fairlie, David P. (2022). Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake. RSC Chemical Biology, 3 (7), 895-904. doi: 10.1039/d1cb00231g
Ozdarska, Katarzyna, Petremant, Maud, Wu, Kai-Chen and Bourguet, Erika (2022). Synthesis of novel pyridazino[1,6-a]indole-2,4(1H,3H)-dione and pyridazino[1,6-a]indol-2(1H)-one via intramolecular electrophilic aromatic substitution. Results in Chemistry, 4 100612, 100612. doi: 10.1016/j.rechem.2022.100612
Mantzourani, Christiana, Gkikas, Dimitrios, Kokotos, Alexandros, Nummela, Pirjo, Theodoropoulou, Maria A., Wu, Kai-Chen, Fairlie, David P., Politis, Panagiotis K., Ristimäki, Ari and Kokotos, George (2021). Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity. Bioorganic Chemistry, 114 105132, 1-9. doi: 10.1016/j.bioorg.2021.105132
Mak, Jeffrey Y. W., Wu, Kai-Chen, Gupta, Praveer K., Barbero, Sheila, McLaughlin, Maddison G., Lucke, Andrew J., Tng, Jiahui, Lim, Junxian, Loh, Zhixuan, Sweet, Matthew J, Reid, Robert C., Liu, Ligong and Fairlie, David P. (2021). HDAC7 inhibition by phenacetyl and phenylbenzoyl hydroxamates. Journal of Medicinal Chemistry, 64 (4), 2186-2204. doi: 10.1021/acs.jmedchem.0c01967
Jiang, Yuhong, Lim, Junxian, Wu, Kai‐Chen, Xu, Weijun, Suen, Jacky Y. and Fairlie, David P. (2021). PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR. British Journal of Pharmacology, 178 (4) bph.15332, 913-932. doi: 10.1111/bph.15332
Tng, Jiahui, Lim, Junxian, Wu, Kai-Chen, Lucke, Andrew J., Xu, Weijun, Reid, Robert C. and Fairlie, David P. (2020). Achiral derivatives of hydroxamate AR-42 potently inhibit class I HDAC enzymes and cancer cell proliferation. Journal of Medicinal Chemistry, 63 (11) acs.jmedchem.0c00230, 5956-5971. doi: 10.1021/acs.jmedchem.0c00230
Rowley, Jessica A., Reid, Robert C., Poon, Eunice K. Y., Wu, Kai-Chen, Lim, Junxian, Lohman, Rink-Jan, Hamidon, Johan K., Yau, Mei-Kwan, Halili, Maria A., Durek, Thomas, Iyer, Abishek and Fairlie, David P. (2020). Potent thiophene antagonists of human complement C3a receptor with anti-inflammatory activity. Journal of Medicinal Chemistry, 63 (2) acs.jmedchem.9b00927, 529-541. doi: 10.1021/acs.jmedchem.9b00927
de Araujo, Aline D., Lim, Junxian, Wu, Kai-Chen, Xiang, Yibin, Good, Andrew C., Skerlj, Renato and Fairlie, David P. (2018). Bicyclic helical peptides as dual inhibitors selective for Bcl2A1 and Mcl-1 proteins. Journal of Medicinal Chemistry, 61 (7), 2962-2972. doi: 10.1021/acs.jmedchem.8b00010
Jiang, Yuhong, Yau, Mei-Kwan, Lim, Junxian, Wu, Kai-Chen, Xu, Weijun, Suen, Jacky Y and Fairlie, David P (2018). A potent antagonist of protease-activated receptor 2 that inhibits multiple signaling functions in human cancer cells. The Journal of pharmacology and experimental therapeutics, 364 (2), 246-257. doi: 10.1124/jpet.117.245027
Lohman, Rink-Jan, Hamidon, Johan K., Reid, Robert C., Rowley, Jessica A., Yau, Mei-Kwan, Halili, Maria A., Nielsen, Daniel S., Lim, Junxian, Wu, Kai-Chen, Loh, Zhixuan, Do, Anh, Suen, Jacky Y., Iyer, Abishek and Fairlie, David P. (2017). Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nature Communications, 8 (1) 351, 351. doi: 10.1038/s41467-017-00414-w
Dantas de Araujo, Aline, Wu, Chongyang, Wu, Kai-Chen, Reid, Robert C., Durek, Thomas, Lim, Junxian and Fairlie, David P. (2017). Europium-labeled synthetic C3a protein as a novel fluorescent probe for human complement C3a receptor. Bioconjugate Chemistry, 28 (6), 1669-1676. doi: 10.1021/acs.bioconjchem.7b00132
Jiang, Yuhong, Yau, Mei-Kwan, Kok, W. Mei, Lim, Junxian, Wu, Kai-Chen, Liu, Ligong, Hill, Timothy A., Suen, Jacky Y. and Fairlie, David P. (2017). Biased signaling by agonists of protease activated receptor 2. ACS Chemical Biology, 12 (5), 1217-1226. doi: 10.1021/acschembio.6b01088
Xu, Weijun, Lim, Junxian, Goh, Chai-Yeen, Suen, Jacky Y., Jiang, Yuhong, Yau, Mei-Kwan, Wu, Kai-Chen, Liu, Ligong and Fairlie, David P. (2015). Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2. Journal of Chemical Information and Modeling, 55 (10), 2079-2084. doi: 10.1021/acs.jcim.5b00500

Conference Papers

Fairlie, David, Reid, Robert, Rowley, Jessica, Wu, Kai-Chen, Yau, Mei-Kwan, Lim, Junxian and Iyer, Abishek (2019). Heterocycles for switching GPCR ligand conformation and activity. National Meeting of the American Chemical Society (ACS), Orlando, FL United States, 31 March-4 April 2019. Washington, DC United States: American Chemical Society.
Wu, Chongyang, de Araujo, Aline, Wu, Kai-Chen, Reid, Robert, Durek, Thomas, Lim, Junxian and Fairlie, David (2018). Chemical synthesis and applications of a novel fluorescent probe for human complement C3a receptor. 256th National Meeting and Exposition of the American-Chemical-Society (ACS) - Nanoscience, Nanotechnology and Beyond, Boston Ma, Aug 19-23, 2018. WASHINGTON: AMER CHEMICAL SOC.
Australian Aboriginal Flag Torres Strait Islander Flag UQ acknowledges the Traditional Owners and their custodianship of the lands on which UQ is situated. — Reconciliation at UQ
  • Media

    • Media team contacts
    • Find a subject matter expert
    • UQ news
  • Working at UQ

    • Current staff
    • Careers at UQ
    • Strategic plan
    • Staff support
    • IT support for staff
  • Current students

    • my.UQ
    • Programs and courses
    • Key dates
    • Student support
    • IT support for students
  • Library

    • Library
    • Locations and hours
    • Library services
    • Research tools
  • Contact

    • Contact UQ
    • Make a complaint
    • Faculties, schools, institutes and centres
    • Divisions and departments
    • Campuses, maps and transport
    • Media team contacts
    • Find a subject matter expert
    • UQ news
    • Current staff
    • Careers at UQ
    • Strategic plan
    • Staff support
    • IT support for staff
    • my.UQ
    • Programs and courses
    • Key dates
    • Student support
    • IT support for students
    • Library
    • Locations and hours
    • Library services
    • Research tools
    • Contact UQ
    • Make a complaint
    • Faculties, schools, institutes and centres
    • Divisions and departments
    • Campuses, maps and transport
Web login
  • © The University of Queensland
  • ABN: 63 942 912 684
  • CRICOS: 00025B
  • TEQSA: PRV12080
  • Privacy and terms of use
  • Accessibility
  • Right to information
  • Feedback